%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Olga Ksionda, Marsilius Mues, Anica M. Wandler, Lisa Donker, Milou Tenhagen, Jesse Jun, Gregory S. Ducker, Ksenia Matlawska-Wasowska, Kevin Shannon, Kevan M. Shokat, Jeroen P. Roose
Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref002)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref003)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref004)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref005)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref006)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref007)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref008)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref009)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref015)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref016)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref017)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref018)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref006)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref017)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref019)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref021)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref021)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref024)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref021)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref025)>>
endobj
37 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref024)>>
endobj
38 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref026)>>
endobj
39 0 obj
<>/Border[0 0 0]/A 40 0 R>>
endobj
40 0 obj
<>
endobj
15 0 obj
[41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R]
endobj
41 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 680.2299 m
199.9998 680.2299 l
199.9998 680.73 l
575.9997 680.73 l
f*
0.83 0.64 0.02 0 k
378.822 575.9433 m
383.5843 575.9433 l
h
f*
446.0598 549.9213 m
450.822 549.9213 l
h
f*
393.052 484.8945 m
397.8142 484.8945 l
h
f*
235.6157 458.9291 m
240.378 458.9291 l
h
f*
433.4173 445.9465 m
438.1795 445.9465 l
h
f*
442.6016 445.9465 m
447.3638 445.9465 l
h
f*
404.8441 419.9244 m
409.6063 419.9244 l
h
f*
414.085 419.9244 m
418.8472 419.9244 l
h
f*
203.4142 380.9197 m
208.1764 380.9197 l
h
f*
213.3354 380.9197 m
222.8598 380.9197 l
h
f*
424.063 354.8976 m
433.5874 354.8976 l
h
f*
284.7118 237.9402 m
294.2362 237.9402 l
h
f*
298.6583 237.9402 m
308.1827 237.9402 l
h
f*
283.6346 211.9181 m
288.3969 211.9181 l
h
f*
292.8189 211.9181 m
302.2866 211.9181 l
h
f*
306.7087 211.9181 m
316.2331 211.9181 l
h
f*
321.4488 211.9181 m
330.9165 211.9181 l
h
f*
386.9858 198.9354 m
396.5102 198.9354 l
h
f*
401.6693 198.9354 m
411.1937 198.9354 l
h
f*
222.5197 185.8961 m
232.0441 185.8961 l
h
f*
236.5228 185.8961 m
246.0472 185.8961 l
h
f*
203.4142 172.9134 m
212.9386 172.9134 l
h
f*
217.3606 172.9134 m
226.885 172.9134 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(that)Tj
1.8738 0 Td
(can)Tj
1.8142 0 Td
(resolve)Tj
3.4015 0 Td
(biochemical)Tj
5.4306 0 Td
(signals)Tj
3.2882 0 Td
(in)Tj
0.9846 0 Td
(heterogeneous)Tj
6.8091 0 Td
(cell)Tj
1.6948 0 Td
(population)Tj
4.5534 0 Td
(s)Tj
0.7161 0 Td
(so)Tj
1.2651 0 Td
(that)Tj
1.8679 0 Td
(combination)Tj
-33.6993 -1.474 Td
(therapy)Tj
3.5149 0 Td
(can)Tj
1.8142 0 Td
(be)Tj
1.3188 0 Td
(designed)Tj
4.2251 0 Td
(in)Tj
0.9847 0 Td
(a)Tj
0.7698 0 Td
(rational)Tj
3.4493 0 Td
(manner.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 646.0157 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 629.0078 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(T)Tj
0.8277 0 Td
(cell)Tj
1.5533 0 Td
(acute)Tj
2.3188 0 Td
(lymphoblastic)Tj
5.828 0 Td
(leukemia)Tj
3.8551 0 Td
(\(T-ALL\))Tj
3.6169 0 Td
(is)Tj
0.8448 0 Td
(an)Tj
1.1962 0 Td
(aggressive)Tj
4.2406 0 Td
(hematologic)Tj
5.1363 0 Td
(cancer)Tj
2.8403 0 Td
(characterized)Tj
-32.258 -1.2982 Td
(by)Tj
1.1792 0 Td
(abnormal)Tj
4.0875 0 Td
(growth)Tj
3.0727 0 Td
(and)Tj
1.7348 0 Td
(proliferation)Tj
5.2668 0 Td
(of)Tj
1.0148 0 Td
(early)Tj
2.1486 0 Td
(T)Tj
0.8277 0 Td
(cell)Tj
1.5591 0 Td
(progenitors.)Tj
5.0853 0 Td
(T-ALL)Tj
2.9423 0 Td
(affects)Tj
2.7383 0 Td
(children)Tj
3.5546 0 Td
(and)Tj
-35.2117 -1.3039 Td
(adults,)Tj
2.8402 0 Td
(and)Tj
1.7292 0 Td
(despite)Tj
3.0387 0 Td
(substantial)Tj
4.5014 0 Td
(progress)Tj
3.6 0 Td
(with)Tj
1.9955 0 Td
(modern)Tj
3.4186 0 Td
(chemotherapy,)Tj
6.1738 0 Td
(the)Tj
1.4684 0 Td
(prognosis)Tj
4.1272 0 Td
(remains)Tj
-32.893 -1.2983 Td
(poor)Tj
2.1203 0 Td
(for)Tj
1.3889 0 Td
(patients)Tj
3.3676 0 Td
(who)Tj
1.9388 0 Td
(relapse.)Tj
3.2202 0 Td
(Currently,)Tj
4.354 0 Td
(the)Tj
1.4683 0 Td
(5-year)Tj
2.7269 0 Td
(overall)Tj
2.9027 0 Td
(survival)Tj
3.3392 0 Td
(rate)Tj
1.7461 0 Td
(is)Tj
0.8504 0 Td
(approximately)Tj
5.9754 0 Td
(80%)Tj
-35.3988 -1.2983 Td
(for)Tj
1.3832 0 Td
(children)Tj
3.5547 0 Td
(with)Tj
2.0012 0 Td
(T-ALL)Tj
2.9424 0 Td
(and)Tj
1.7291 0 Td
(45%)Tj
1.9275 0 Td
(for)Tj
1.389 0 Td
(adults)Tj
2.6135 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5988 0 Td
(Modern)Tj
3.4922 0 Td
(treatment)Tj
4.1386 0 Td
(regimens)Tj
3.8948 0 Td
(consist)Tj
2.9877 0 Td
(of)Tj
1.0147 0 Td
(poly-)Tj
-34.6674 -1.3039 Td
(chemotherapy)Tj
5.947 0 Td
(with)Tj
1.9956 0 Td
(cytotoxic)Tj
3.8664 0 Td
(and)Tj
1.7291 0 Td
(genotoxic)Tj
4.1273 0 Td
(drugs)Tj
2.4717 0 Td
(that)Tj
1.7802 0 Td
(both)Tj
2.0579 0 Td
(cause)Tj
2.3925 0 Td
(substantial)Tj
4.5013 0 Td
(acute)Tj
2.3244 0 Td
(toxicity)Tj
-33.1934 -1.2982 Td
(and)Tj
1.7291 0 Td
(are)Tj
1.4513 0 Td
(associated)Tj
4.2519 0 Td
(with)Tj
2.0013 0 Td
(a)Tj
0.652 0 Td
(variety)Tj
2.9253 0 Td
(of)Tj
1.0148 0 Td
(late)Tj
1.6214 0 Td
(adverse)Tj
3.2145 0 Td
(health)Tj
2.6759 0 Td
(effects)Tj
2.7269 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.6044 0 Td
(More)Tj
2.4094 0 Td
(specific)Tj
3.1918 0 Td
(and)Tj
1.7348 0 Td
(less)Tj
1.61 0 Td
(toxic)Tj
-34.8148 -1.2983 Td
(therapies)Tj
3.8437 0 Td
(are)Tj
1.4457 0 Td
(therefore)Tj
3.8551 0 Td
(desired)Tj
3.1237 0 Td
(to)Tj
1.0262 0 Td
(improve)Tj
3.5773 0 Td
(disease)Tj
3.0217 0 Td
(outcomes)Tj
4.0875 0 Td
(and)Tj
1.7291 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(life)Tj
1.4457 0 Td
(both)Tj
2.0579 0 Td
(during)Tj
-33.1821 -1.3039 Td
(and)Tj
1.7291 0 Td
(after)Tj
2.0352 0 Td
(treatment.)Tj
4.3597 0 Td
(One)Tj
1.9389 0 Td
(attractive)Tj
3.9231 0 Td
(strategy)Tj
3.3279 0 Td
(for)Tj
1.3833 0 Td
(achieving)Tj
4.0365 0 Td
(this)Tj
1.6724 0 Td
(goal)Tj
1.8708 0 Td
(is)Tj
0.8504 0 Td
(to)Tj
1.0262 0 Td
(target)Tj
2.5058 0 Td
(aberrant)Tj
3.6113 0 Td
(signal)Tj
-34.2706 -1.2983 Td
(transduction)Tj
5.3291 0 Td
(pathways)Tj
3.9344 0 Td
(that)Tj
1.7802 0 Td
(drive)Tj
2.262 0 Td
(the)Tj
1.4683 0 Td
(growth)Tj
3.0728 0 Td
(and)Tj
1.7348 0 Td
(survival)Tj
3.3335 0 Td
(of)Tj
1.0148 0 Td
(leukemic)Tj
3.8494 0 Td
(blasts.)Tj
-26.5831 -1.2983 Td
(The)Tj
1.7858 0 Td
(Notch)Tj
2.7099 0 Td
(pathway)Tj
3.5716 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2019 0 Td
(attractive)Tj
3.9231 0 Td
(candidate)Tj
4.1046 0 Td
(for)Tj
1.3832 0 Td
(targeted)Tj
3.464 0 Td
(inhibition,)Tj
4.4503 0 Td
(since)Tj
2.2451 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(half)Tj
-35.2571 -1.3039 Td
(of)Tj
1.0147 0 Td
(all)Tj
1.1452 0 Td
(T-ALLs)Tj
3.3052 0 Td
(harbor)Tj
2.9367 0 Td
(mutations)Tj
4.2803 0 Td
(in)Tj
1.0374 0 Td
(this)Tj
1.6725 0 Td
(pathway)Tj
3.5716 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.5987 0 Td
(However,)Tj
4.0762 0 Td
(the)Tj
1.474 0 Td
(dose)Tj
2.0353 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6577 0 Td
(first)Tj
2.194 0 Td
(genera-)Tj
-34.3897 -1.2982 Td
(tion)Tj
2.228 0 Td
(Notch)Tj
2.7099 0 Td
(inhibitor)Tj
3.7757 0 Td
(was)Tj
1.6894 0 Td
(limited)Tj
3.0671 0 Td
(by)Tj
1.1792 0 Td
(gastrointestinal)Tj
6.3439 0 Td
(toxicity)Tj
3.1975 0 Td
(and)Tj
1.7234 0 Td
(this)Tj
1.6724 0 Td
(agent)Tj
2.3811 0 Td
(had)Tj
1.7065 0 Td
(limited)Tj
3.0614 0 Td
(clinical)Tj
-34.7355 -1.2983 Td
(efficacy)Tj
3.2201 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.6044 0 Td
(Hyperactive)Tj
5.0513 0 Td
(Ras)Tj
1.6384 0 Td
(signaling)Tj
3.8211 0 Td
(is)Tj
0.8504 0 Td
(another)Tj
3.3278 0 Td
(attractive)Tj
3.9232 0 Td
(candidate)Tj
4.1045 0 Td
(target)Tj
2.5115 0 Td
(in)Tj
1.0374 0 Td
(T-ALL.)Tj
3.1692 0 Td
(Onco-)Tj
-34.2593 -1.2983 Td
(genic)Tj
2.347 0 Td
(Ras)Tj
1.6384 0 Td
(signals)Tj
2.9027 0 Td
(are)Tj
1.4457 0 Td
(observed)Tj
3.7984 0 Td
(in)Tj
1.0318 0 Td
(~65%)Tj
2.5114 0 Td
(of)Tj
1.0148 0 Td
(T-ALL)Tj
2.9424 0 Td
(patients)Tj
3.3675 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(6)Tj
0 g
(],)Tj
1.2642 0 Td
(either)Tj
2.5285 0 Td
(via)Tj
1.3777 0 Td
(an)Tj
1.2018 0 Td
(oncogenic)Tj
/F12 1 Tf
4.3313 0 Td
[()-16()22()]TJ
/F8 1 Tf
-34.9622 -1.3039 Td
(mutation,)Tj
4.1442 0 Td
(inactivation)Tj
4.9662 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
/F12 1 Tf
1.474 0 Td
[()]TJ
/F8 1 Tf
1.8936 0 Td
(tumor)Tj
2.7439 0 Td
(suppressor,)Tj
4.7678 0 Td
(or)Tj
1.0942 0 Td
(overexpression)Tj
6.2249 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(activator)Tj
3.7077 0 Td
(Ras)Tj
-34.5144 -1.2982 Td
(guanine)Tj
3.4355 0 Td
(nucleotide)Tj
4.4107 0 Td
(releasing)Tj
3.7587 0 Td
(protein)Tj
3.1578 0 Td
(1)Tj
0.6916 0 Td
(\(RasGRP1\))Tj
4.6885 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2643 0 Td
(8)Tj
0 g
(].)Tj
1.2585 0 Td
(As)Tj
1.2643 0 Td
(effective)Tj
3.5092 0 Td
(small)Tj
2.3301 0 Td
(molecule)Tj
3.8381 0 Td
(inhibitors)Tj
-33.6073 -1.2983 Td
(of)Tj
1.0147 0 Td
(either)Tj
2.5285 0 Td
(Ras)Tj
1.6384 0 Td
(or)Tj
1.0999 0 Td
(RasGRP1)Tj
4.0081 0 Td
(do)Tj
1.253 0 Td
(not)Tj
1.576 0 Td
(currently)Tj
3.8834 0 Td
(exist,)Tj
2.2621 0 Td
(we)Tj
1.3266 0 Td
(focused)Tj
3.2768 0 Td
(on)Tj
1.2756 0 Td
(class)Tj
2.0466 0 Td
(I)Tj
0.5613 0 Td
(phosphoinositide)Tj
-27.751 -1.3039 Td
(3-kinases)Tj
3.9344 0 Td
(\(PI3Ks\),)Tj
3.5376 0 Td
(which)Tj
2.6476 0 Td
(are)Tj
1.4513 0 Td
(activated)Tj
3.7814 0 Td
(by)Tj
1.1792 0 Td
(Ras-dependent)Tj
6.2248 0 Td
(and)Tj
1.7348 0 Td
(Ras-independent)Tj
7.0412 0 Td
(mechanisms)Tj
-31.5323 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
3.067 0 Td
(When)Tj
2.6872 0 Td
(in)Tj
1.0375 0 Td
(its)Tj
1.1452 0 Td
(active,)Tj
2.7439 0 Td
(GTP-bound)Tj
5.074 0 Td
(conformation,)Tj
5.9641 0 Td
(Ras)Tj
1.6384 0 Td
(binds)Tj
2.4321 0 Td
(to)Tj
1.0261 0 Td
(and)Tj
1.7292 0 Td
(activates)Tj
3.6169 0 Td
(PI3K)Tj
2.2677 0 Td
(at)Tj
0.9525 0 Td
(the)Tj
-35.3818 -1.2983 Td
(plasma)Tj
3.033 0 Td
(membrane,)Tj
4.7905 0 Td
(and)Tj
1.7291 0 Td
(PI3K's)Tj
2.846 0 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0318 0 Td
(oncogenic)Tj
4.337 0 Td
(cell)Tj
1.5591 0 Td
(growth)Tj
3.0727 0 Td
(and)Tj
1.7291 0 Td
(protein)Tj
3.1521 0 Td
(translation)Tj
4.5354 0 Td
(makes)Tj
2.7553 0 Td
(it)Tj
-36.3399 -1.3039 Td
(an)Tj
1.2018 0 Td
(attractive)Tj
3.9232 0 Td
(candidate)Tj
4.1045 0 Td
(for)Tj
1.3833 0 Td
(targeted)Tj
3.4639 0 Td
(anti-cancer)Tj
4.7452 0 Td
(therapy)Tj
3.2428 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
2.0806 0 Td
(PI3Ks)Tj
2.6249 0 Td
(are)Tj
1.4513 0 Td
(divided)Tj
3.2145 0 Td
(into)Tj
1.8425 0 Td
(four)Tj
1.9162 0 Td
(clas-)Tj
-35.1947 -1.2982 Td
(ses)Tj
1.3662 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(their)Tj
2.109 0 Td
(structures)Tj
4.1839 0 Td
(and)Tj
1.7291 0 Td
(substrate)Tj
3.7984 0 Td
(specificities.)Tj
5.0343 0 Td
(Members)Tj
4.0195 0 Td
(of)Tj
1.0148 0 Td
(class)Tj
2.0466 0 Td
(I,)Tj
0.7824 0 Td
(the)Tj
1.474 0 Td
(focus)Tj
2.3244 0 Td
(here,)Tj
2.194 0 Td
(are)Tj
-35.824 -1.2983 Td
(heterodimeric)Tj
5.8676 0 Td
(proteins)Tj
3.515 0 Td
(consisting)Tj
4.2689 0 Td
(of)Tj
1.0148 0 Td
(regulatory)Tj
4.32 0 Td
(and)Tj
1.7291 0 Td
(catalytic)Tj
3.4979 0 Td
(subunits.)Tj
3.8438 0 Td
(Upon)Tj
2.5285 0 Td
(activation,)Tj
4.3823 0 Td
(class)Tj
2.041 0 Td
(I)Tj
-37.0089 -1.2983 Td
(PI3Ks)Tj
2.6305 0 Td
(produce)Tj
3.5149 0 Td
(PI3P,)Tj
2.3811 0 Td
(PI\(3,4\)P)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 318.3874 315.3259 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 324.17 317.0267 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(and)Tj
1.7291 0 Td
(PI\(3,4,5\)P)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 381.6566 315.3259 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 387.3826 317.0267 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\(Phosphatidylinositol)Tj
8.793 0 Td
(\(3,4,5\)-trisphosphate\).)Tj
9.1048 0 Td
(PI)Tj
-36.6346 -1.3039 Td
(\(3,4,5\)P)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 231.1937 302.3433 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 236.9196 303.9874 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(serves)Tj
2.6135 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(plasma)Tj
3.0331 0 Td
(membrane)Tj
4.5637 0 Td
(anchor)Tj
3.0331 0 Td
(for)Tj
1.3833 0 Td
(cytoplasmic)Tj
4.9776 0 Td
(proteins)Tj
3.5092 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(PDK1)Tj
2.6646 0 Td
(and)Tj
1.7291 0 Td
(Akt)Tj
-35.9486 -1.2982 Td
(that)Tj
1.7744 0 Td
(signals)Tj
2.9083 0 Td
(to)Tj
1.0204 0 Td
(promote)Tj
3.668 0 Td
(cell)Tj
1.5591 0 Td
(cycle)Tj
2.1883 0 Td
(progression)Tj
4.9209 0 Td
(and)Tj
1.7292 0 Td
(growth.)Tj
3.2995 0 Td
(Inhibitors)Tj
4.2179 0 Td
(that)Tj
1.7745 0 Td
(interfere)Tj
3.6396 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
-34.6957 -1.2983 Td
(PI3K)Tj
2.2677 0 Td
(pathway)Tj
3.5715 0 Td
(are)Tj
1.4457 0 Td
(currently)Tj
3.8891 0 Td
(being)Tj
2.4264 0 Td
(evaluated)Tj
3.9912 0 Td
(in)Tj
1.0374 0 Td
(many)Tj
2.4775 0 Td
(clinical)Tj
3.0727 0 Td
(trials)Tj
2.1997 0 Td
(\(Clinicaltrials.gov\).)Tj
-25.1827 -1.3039 Td
(Almost)Tj
3.1406 0 Td
(50%)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(pediatric)Tj
3.7474 0 Td
(T-ALL)Tj
2.9423 0 Td
(patients)Tj
3.3675 0 Td
(harbor)Tj
2.9424 0 Td
(mutations)Tj
4.2803 0 Td
(in)Tj
1.0318 0 Td
(genes)Tj
2.4434 0 Td
(encoding)Tj
3.9345 0 Td
(protein)Tj
3.1521 0 Td
(com-)Tj
-35.1209 -1.2983 Td
(ponents)Tj
3.4242 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4683 0 Td
(PI3K-Akt)Tj
4.0989 0 Td
(pathway)Tj
3.5716 0 Td
(including)Tj
/F12 1 Tf
4.0422 0 Td
[()14( \n)]TJ
/F8 1 Tf
(,)Tj
/F12 1 Tf
3.702 0 Td
[( )]TJ
/F8 1 Tf
(,)Tj
2.3301 0 Td
(and)Tj
/F12 1 Tf
1.7348 0 Td
[(\r)]TJ
/F8 1 Tf
(,)Tj
2.8233 0 Td
(a)Tj
0.6576 0 Td
(major)Tj
2.6079 0 Td
(negative)Tj
3.5319 0 Td
(regu-)Tj
-35.0075 -1.2982 Td
(lator)Tj
2.0749 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4682 0 Td
(pathway)Tj
3.5717 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(18)Tj
0 g
(].)Tj
1.7404 0 Td
(While)Tj
2.6476 0 Td
(T-ALL)Tj
2.9423 0 Td
(cells)Tj
1.9219 0 Td
(frequently)Tj
4.3086 0 Td
(activate)Tj
3.2542 0 Td
(the)Tj
1.4683 0 Td
(Ras-PI3K)Tj
4.0365 0 Td
(pathway,)Tj
-32.1842 -1.3039 Td
(there)Tj
2.262 0 Td
(is)Tj
0.8504 0 Td
(marked)Tj
3.2937 0 Td
(heterogeneity)Tj
5.6523 0 Td
(across)Tj
2.6759 0 Td
(different)Tj
3.6566 0 Td
(leukemias)Tj
4.218 0 Td
(and)Tj
1.7291 0 Td
(this)Tj
1.6724 0 Td
(question)Tj
3.6623 0 Td
(has)Tj
1.5421 0 Td
(not)Tj
1.576 0 Td
(been)Tj
2.1203 0 Td
(ana-)Tj
-34.9111 -1.2983 Td
(lyzed)Tj
2.279 0 Td
(systematically)Tj
5.7429 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2585 0 Td
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.389 0 Td
(19)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(].)Tj
/F12 1 Tf
3.2031 0 Td
[()39()]TJ
1.0772 0 Td
[()-13()14()7()20()]TJ
/F8 1 Tf
2.0409 0 Td
(data)Tj
1.9106 0 Td
(from)Tj
2.2053 0 Td
(human)Tj
3.0727 0 Td
(T-ALL)Tj
2.9424 0 Td
(cell)Tj
1.5534 0 Td
(lines)Tj
2.0636 0 Td
(suggest)Tj
3.1181 0 Td
(that)Tj
1.7744 0 Td
(inhi-)Tj
-35.6311 -1.2983 Td
(bition)Tj
2.6135 0 Td
(of)Tj
1.0148 0 Td
(PI3K)Tj
2.2676 0 Td
(may)Tj
1.9275 0 Td
(have)Tj
2.0636 0 Td
(anti-leukemic)Tj
5.743 0 Td
(effects)Tj
2.7269 0 Td
([)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(].)Tj
3.5433 0 Td
(However,)Tj
4.0819 0 Td
(there)Tj
2.262 0 Td
(are)Tj
1.4457 0 Td
(only)Tj
1.9785 0 Td
(limited)Tj
/F12 1 Tf
3.0728 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F8 1 Tf
-35.7559 -1.3039 Td
(data)Tj
1.9105 0 Td
([)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7405 0 Td
(25)Tj
0 g
(])Tj
1.5079 0 Td
(and)Tj
1.7348 0 Td
(results)Tj
2.8063 0 Td
(from)Tj
2.2053 0 Td
(studies)Tj
2.9877 0 Td
(of)Tj
1.0148 0 Td
(isoform-specific)Tj
6.6614 0 Td
(PI3K)Tj
2.2677 0 Td
(inhibitors)Tj
4.1442 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.1203 0 Td
(conflicting)Tj
-33.1593 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(26)Tj
0 g
(].)Tj
1.7347 0 Td
(To)Tj
1.3379 0 Td
(better)Tj
2.5455 0 Td
(assess)Tj
2.5228 0 Td
(PI3K)Tj
2.2677 0 Td
(inhibitors)Tj
4.1386 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(potential)Tj
3.7587 0 Td
(therapeutic)Tj
4.7338 0 Td
(strategy)Tj
3.3222 0 Td
(for)Tj
1.389 0 Td
(T-ALL,)Tj
3.1691 0 Td
(we)Tj
1.3266 0 Td
(per-)Tj
-35.6538 -1.2982 Td
(formed)Tj
3.1577 0 Td
(comprehensive)Tj
6.2871 0 Td
(analyses)Tj
3.481 0 Td
(of)Tj
1.0148 0 Td
(PI3K-Akt)Tj
4.0988 0 Td
(signaling)Tj
3.8211 0 Td
(in)Tj
1.0375 0 Td
(T-ALL)Tj
2.9423 0 Td
(cells)Tj
1.9219 0 Td
(using)Tj
2.3868 0 Td
(multiplex,)Tj
4.2576 0 Td
(multi-)Tj
-34.4066 -1.2983 Td
(parameter)Tj
4.3142 0 Td
(flow)Tj
1.9445 0 Td
(cytometry)Tj
4.269 0 Td
(with)Tj
1.9956 0 Td
(pan-)Tj
2.0749 0 Td
(and)Tj
1.7291 0 Td
(isoform-specific)Tj
6.6614 0 Td
(PI3K)Tj
2.2677 0 Td
(inhibitors,)Tj
4.3653 0 Td
(tested)Tj
2.5569 0 Td
(the)Tj
1.4683 0 Td
(effect)Tj
2.3641 0 Td
(of)Tj
-36.011 -1.3039 Td
(candidate)Tj
4.1044 0 Td
(compounds)Tj
4.9606 0 Td
(to)Tj
1.0205 0 Td
(induce)Tj
2.9423 0 Td
(cell)Tj
1.5591 0 Td
(death)Tj
2.4321 0 Td
(and)Tj
1.7291 0 Td
(inhibit)Tj
2.9027 0 Td
(proliferation,)Tj
5.4935 0 Td
(and)Tj
1.7291 0 Td
(performed)Tj
4.4674 0 Td
(preclinical)Tj
-33.3408 -1.2983 Td
(mouse)Tj
2.8573 0 Td
(trials)Tj
2.1995 0 Td
(with)Tj
1.9956 0 Td
(pan-)Tj
2.0693 0 Td
(and)Tj
/F13 1 Tf
1.7291 0 Td
(\r)Tj
/F8 1 Tf
(-isoform-specific)Tj
7.4721 0 Td
(PI3K)Tj
2.2677 0 Td
(inhibitors.)Tj
4.3653 0 Td
(Our)Tj
1.8652 0 Td
(results)Tj
2.812 0 Td
(demonstrate)Tj
5.2327 0 Td
(that)Tj
-34.8658 -1.2982 Td
(combination)Tj
5.346 0 Td
(therapy)Tj
3.2485 0 Td
(with)Tj
1.9955 0 Td
(PI3K)Tj
2.2677 0 Td
(inhibitors)Tj
4.1443 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6576 0 Td
(promising)Tj
4.3427 0 Td
(avenue)Tj
3.033 0 Td
(for)Tj
1.3833 0 Td
(future)Tj
2.6589 0 Td
(molecular)Tj
4.2179 0 Td
(therapy)Tj
-34.1401 -1.3039 Td
(but)Tj
1.5533 0 Td
(also)Tj
1.7688 0 Td
(warn)Tj
2.2563 0 Td
(that)Tj
1.7802 0 Td
(thorough)Tj
3.9514 0 Td
(studies)Tj
2.9821 0 Td
(with)Tj
2.0012 0 Td
(high-resolution)Tj
6.4119 0 Td
(methods)Tj
3.685 0 Td
(are)Tj
1.4514 0 Td
(required)Tj
3.6396 0 Td
(to)Tj
1.0262 0 Td
(fully)Tj
1.9785 0 Td
(resolve)Tj
-34.4859 -1.2983 Td
(complex)Tj
3.6226 0 Td
(biochemical)Tj
5.0626 0 Td
(signals)Tj
2.9026 0 Td
(in)Tj
1.0375 0 Td
(heterogeneous)Tj
6.0264 0 Td
(cell)Tj
1.5591 0 Td
(populations)Tj
4.9549 0 Td
(of)Tj
1.0148 0 Td
(T-ALL.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 415.8425 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PI3)Tj
1.7008 0 Td
(kinase)Tj
3.0543 0 Td
(signaling)Tj
4.0819 0 Td
(analysis)Tj
3.763 0 Td
(in)Tj
0.978 0 Td
(T)Tj
0.8221 0 Td
(cell)Tj
1.6866 0 Td
(leukemia)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01938)Tj
4.089 0 Td
(49)Tj
0 g
2.0906 0 Td
(May)Tj
2.0906 0 Td
(25,)Tj
1.5803 0 Td
(2018)Tj
35.2349 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(18)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Society\))Tj
3.2386 0 Td
(\(MT\).)Tj
2.289 0 Td
(AMW)Tj
2.3031 0 Td
(is)Tj
0.8362 0 Td
(supporte)Tj
3.2953 0 Td
(d)Tj
0.6945 0 Td
(by)Tj
1.1126 0 Td
(a)Tj
-13.7693 -1.3748 Td
(Postdocto)Tj
3.7701 0 Td
(ral)Tj
1.1409 0 Td
(Fellowship,)Tj
4.3512 0 Td
(PF-14-070)Tj
3.926 0 Td
(-01-TBG,)Tj
3.593 0 Td
(from)Tj
-16.7812 -1.3749 Td
(the)Tj
1.3677 0 Td
(American)Tj
3.7417 0 Td
(Cancer)Tj
2.7851 0 Td
(Society)Tj
2.9339 0 Td
(including)Tj
3.5858 0 Td
(a)Tj
-14.4142 -1.3748 Td
(suppleme)Tj
3.6283 0 Td
(nt)Tj
0.9496 0 Td
(from)Tj
2.0127 0 Td
(the)Tj
1.3677 0 Td
(Hillcrest)Tj
3.2173 0 Td
(Committe)Tj
3.6284 0 Td
(e.)Tj
0.8646 0 Td
(KMS)Tj
-15.6686 -1.3748 Td
(would)Tj
2.4732 0 Td
(like)Tj
1.4457 0 Td
(to)Tj
0.9496 0 Td
(thank)Tj
2.2677 0 Td
(NIH)Tj
1.6512 0 Td
(RO1AI099)Tj
3.8481 0 Td
(245)Tj
1.6441 0 Td
(for)Tj
1.2543 0 Td
(funding.)Tj
/F9 1 Tf
-15.5339 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(KMS)Tj
2.0197 0 Td
(is)Tj
0.8363 0 Td
(an)Tj
1.1126 0 Td
(inventor)Tj
3.2386 0 Td
(on)Tj
1.1693 0 Td
(the)Tj
-16.5686 -1.3748 Td
(UCSF)Tj
2.2819 0 Td
(patent)Tj
2.5157 0 Td
(US)Tj
1.3323 0 Td
(7,585,868)Tj
3.9827 0 Td
(B2)Tj
1.2189 0 Td
(covering)Tj
3.4087 0 Td
(INK128,)Tj
-14.7402 -1.3748 Td
(which)Tj
2.4236 0 Td
(is)Tj
0.8291 0 Td
(licensed)Tj
3.2386 0 Td
(to)Tj
0.9497 0 Td
(Takeda)Tj
2.8559 0 Td
(Pharmace)Tj
3.7417 0 Td
(uticals.)Tj
2.8276 0 Td
(KMS)Tj
-16.8662 -1.3748 Td
(is)Tj
0.8362 0 Td
(a)Tj
0.6378 0 Td
(consultant)Tj
4.0819 0 Td
(to)Tj
0.9496 0 Td
(Takeda)Tj
2.8559 0 Td
(Pharmace)Tj
3.7418 0 Td
(uticals.)Tj
2.8276 0 Td
(The)Tj
-15.9308 -1.3748 Td
(remaining)Tj
3.9331 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(no)Tj
1.1623 0 Td
(potential)Tj
3.3803 0 Td
(conflict)Tj
2.9055 0 Td
(of)Tj
-16.3843 -1.3749 Td
(interest)Tj
2.9693 0 Td
(and)Tj
1.5874 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interes)Tj
2.4874 0 Td
(ts.)Tj
1.1268 0 Td
(There)Tj
2.3173 0 Td
(are)Tj
1.3677 0 Td
(no)Tj
-17.1851 -1.3748 Td
(further)Tj
2.7141 0 Td
(patents,)Tj
3.1678 0 Td
(products)Tj
3.515 0 Td
(in)Tj
0.8858 0 Td
(development)Tj
5.0032 0 Td
(or)Tj
-15.2859 -1.3748 Td
(marketed)Tj
3.6992 0 Td
(products)Tj
3.515 0 Td
(to)Tj
0.9496 0 Td
(declare.)Tj
3.104 0 Td
(This)Tj
1.7787 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4244 0 Td
(alter)Tj
-16.4835 -1.3748 Td
(our)Tj
1.474 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(all)Tj
1.0275 0 Td
(the)Tj
1.3678 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8709 0 Td
(policies)Tj
3.0118 0 Td
(on)Tj
-16.0867 -1.3748 Td
(sharing)Tj
2.9834 0 Td
(data)Tj
1.793 0 Td
(and)Tj
1.5874 0 Td
(materials,)Tj
3.8339 0 Td
(as)Tj
1.063 0 Td
(detailed)Tj
3.0685 0 Td
(online)Tj
2.452 0 Td
(in)Tj
0.8858 0 Td
(the)Tj
-17.667 -1.3748 Td
(guide)Tj
2.2535 0 Td
(for)Tj
ET
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
BT
3.5079 62.717 Td
(authors.)Tj
ET
Q
endstream
endobj
61 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 64 0 R/Contents 65 0 R/TrimBox[0 0 612 792]>>
endobj
64 0 obj
[66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R]
endobj
66 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref006)>>
endobj
67 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g001)>>
endobj
68 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g001)>>
endobj
69 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref006)>>
endobj
70 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref017)>>
endobj
71 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref019)>>
endobj
72 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref021)>>
endobj
73 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g002)>>
endobj
74 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g001)>>
endobj
75 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g002)>>
endobj
76 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g002)>>
endobj
77 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref027)>>
endobj
78 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g002)>>
endobj
79 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g002)>>
endobj
80 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.s001)>>
endobj
81 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.s001)>>
endobj
82 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref006)>>
endobj
83 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.s001)>>
endobj
84 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.g003)>>
endobj
85 0 obj
<>/Border[0 0 0]/Dest(Rpone.0193849.ref028)>>
endobj
86 0 obj
<>/Border[0 0 0]/A 87 0 R>>
endobj
87 0 obj
<>
endobj
65 0 obj
[88 0 R 89 0 R 90 0 R 91 0 R 92 0 R 93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R 102 0 R]
endobj
88 0 obj
<>stream
q
0.83 0.64 0.02 0 k
540.4535 657.0142 m
545.2157 657.0142 l
h
f*
538.1858 552.9827 m
565.6252 552.9827 l
h
f*
200.0126 540 m
211.6913 540 l
h
f*
499.0677 540 m
503.8299 540 l
h
f*
508.3087 540 m
517.7764 540 l
h
f*
522.2551 540 m
531.7795 540 l
h
f*
536.9386 540 m
546.463 540 l
h
f*
487.4457 427.9748 m
514.885 427.9748 l
h
f*
338.9102 388.9701 m
343.6724 388.9701 l
h
f*
366.5764 388.9701 m
378.5953 388.9701 l
h
f*
509.2157 375.9874 m
535.9181 375.9874 l
h
f*
203.3575 336.9827 m
212.7118 336.9827 l
h
f*
383.9244 297.978 m
410.7969 297.978 l
h
f*
271.389 271.9559 m
299.0551 271.9559 l
h
f*
474.9165 258.9732 m
506.948 258.9732 l
h
f*
226.2047 232.9512 m
257.6126 232.9512 l
h
f*
280.1764 232.9512 m
284.8819 232.9512 l
h
f*
471.5717 219.9685 m
503.3197 219.9685 l
h
f*
275.5843 107.9433 m
302.4567 107.9433 l
h
f*
397.7575 94.9039 m
407.0551 94.9039 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
/F14 1 Tf
0 -1.4976 Td
(T-ALL)Tj
3 0 Td
(cells)Tj
2.0173 0 Td
(with)Tj
2.0788 0 Td
(high)Tj
2.0882 0 Td
(PI3K-Akt)Tj
4.2756 0 Td
(signals)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 671.074 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(T-ALL)Tj
2.9423 0 Td
(cells)Tj
1.9162 0 Td
(characterized)Tj
5.5615 0 Td
(by)Tj
1.1792 0 Td
(either)Tj
2.5342 0 Td
(endogenous)Tj
5.057 0 Td
(oncogenic)Tj
4.337 0 Td
(KRas)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 456.2078 675.496 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(G12D)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 476.3338 671.074 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(expression)Tj
4.4673 0 Td
(or)Tj
1.0999 0 Td
(by)Tj
1.1792 0 Td
(over-)Tj
-34.3783 -1.2982 Td
(expression)Tj
4.4617 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(Ras)Tj
1.6328 0 Td
(activator)Tj
3.7076 0 Td
(RasGRP1)Tj
4.0082 0 Td
(generate)Tj
3.6113 0 Td
(two)Tj
1.7065 0 Td
(distinct)Tj
3.2144 0 Td
(oncogenic)Tj
4.3312 0 Td
(Ras)Tj
1.6385 0 Td
(signals)Tj
2.9026 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
1.5988 0 Td
(We)Tj
-35.3024 -1.3039 Td
(selected)Tj
3.3449 0 Td
(murine)Tj
3.1804 0 Td
(T-ALL)Tj
2.9424 0 Td
(cell)Tj
1.559 0 Td
(lines)Tj
2.0636 0 Td
(characterized)Tj
5.5615 0 Td
(by)Tj
1.1793 0 Td
(these)Tj
2.2563 0 Td
(distinct)Tj
3.2088 0 Td
(types)Tj
2.2791 0 Td
(of)Tj
1.0147 0 Td
(Ras)Tj
1.6327 0 Td
(signaling)Tj
3.8267 0 Td
(for)Tj
-34.0494 -1.2983 Td
(Western)Tj
3.6113 0 Td
(blot)Tj
1.7802 0 Td
(analysis)Tj
3.3221 0 Td
(with)Tj
2.0013 0 Td
(an)Tj
1.2019 0 Td
(antibody)Tj
3.7644 0 Td
(that)Tj
1.7744 0 Td
(detects)Tj
2.9764 0 Td
(phosphorylation)Tj
6.8144 0 Td
(on)Tj
1.2755 0 Td
(serine)Tj
2.6135 0 Td
(473)Tj
1.6498 0 Td
(\(S473\))Tj
2.8006 0 Td
(of)Tj
-35.5858 -1.2983 Td
(Akt)Tj
1.6951 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(proxy)Tj
2.5342 0 Td
(for)Tj
1.389 0 Td
(PI3K)Tj
2.2677 0 Td
(pathway)Tj
3.5659 0 Td
(activation)Tj
4.1556 0 Td
(at)Tj
0.9524 0 Td
(baseline.)Tj
3.6567 0 Td
(We)Tj
1.6101 0 Td
(also)Tj
1.7631 0 Td
(treated)Tj
2.9989 0 Td
(cells)Tj
1.9219 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.652 0 Td
(cocktail)Tj
3.3165 0 Td
(of)Tj
-36.1471 -1.2982 Td
(cytokines)Tj
3.9968 0 Td
(important)Tj
4.286 0 Td
(for)Tj
1.3833 0 Td
(T-ALL)Tj
2.9423 0 Td
(proliferation)Tj
/F12 1 Tf
5.2668 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F8 1 Tf
1.8198 0 Td
(\(reviewed)Tj
4.1385 0 Td
(in)Tj
1.0319 0 Td
(\(7\)\))Tj
1.7177 0 Td
(to)Tj
1.0261 0 Td
(investigate)Tj
4.4617 0 Td
(the)Tj
1.4683 0 Td
(magni-)Tj
-34.554 -1.3039 Td
(tutie)Tj
2.0353 0 Td
(of)Tj
1.0148 0 Td
(cytokine-induced)Tj
7.2339 0 Td
(PI3K-Akt)Tj
4.0989 0 Td
(signaling.)Tj
4.0478 0 Td
(We)Tj
1.6101 0 Td
(observed)Tj
3.7927 0 Td
(widespread)Tj
4.7565 0 Td
(phosphorylation)Tj
6.8144 0 Td
(of)Tj
-35.4044 -1.2983 Td
(Akt)Tj
1.6951 0 Td
(\(pAkt\))Tj
2.897 0 Td
(in)Tj
1.0318 0 Td
(T-ALL)Tj
2.9367 0 Td
(cells)Tj
1.9219 0 Td
(with)Tj
1.9955 0 Td
(either)Tj
2.5285 0 Td
(RasGRP1)Tj
4.0025 0 Td
(overexpression)Tj
6.2192 0 Td
(or)Tj
1.0998 0 Td
(an)Tj
1.1962 0 Td
(oncogenic)Tj
/F12 1 Tf
4.3312 0 Td
[( )30()20()]TJ
/F8 1 Tf
2.041 0 Td
(mutation)Tj
-33.8964 -1.2983 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(human)Tj
3.0784 0 Td
(Jurkat)Tj
2.6759 0 Td
(and)Tj
1.7291 0 Td
(MOLT-3)Tj
3.8324 0 Td
(T-ALL)Tj
2.9424 0 Td
(cell)Tj
1.5647 0 Td
(lines,)Tj
2.2904 0 Td
(yet)Tj
1.3946 0 Td
(with)Tj
1.9956 0 Td
(heterogeneous)Tj
6.032 0 Td
(intensity)Tj
3.685 0 Td
(and)Tj
1.7291 0 Td
(dif-)Tj
-35.7162 -1.3039 Td
(ferent)Tj
2.5738 0 Td
(patterns)Tj
3.4696 0 Td
(of)Tj
1.0148 0 Td
(activation)Tj
4.1556 0 Td
(either)Tj
2.5285 0 Td
(at)Tj
0.9524 0 Td
(baseline)Tj
3.4299 0 Td
(and/or)Tj
2.9424 0 Td
(following)Tj
3.9741 0 Td
(cytokine)Tj
3.6396 0 Td
(stimulation)Tj
4.7962 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(Fig)Tj
1.8821 0 Td
(1A)Tj
0 g
/F8 1 Tf
()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
-35.359 -1.2983 Td
(1C)Tj
0 g
/F8 1 Tf
(\).)Tj
1.9559 0 Td
(These)Tj
2.5625 0 Td
(results)Tj
2.8119 0 Td
(expand)Tj
3.1351 0 Td
(on)Tj
1.2756 0 Td
(previous)Tj
3.651 0 Td
(findings)Tj
3.4923 0 Td
(in)Tj
1.0375 0 Td
(human)Tj
3.0784 0 Td
(T-ALL)Tj
2.9423 0 Td
(cell)Tj
1.5591 0 Td
(lines)Tj
2.0635 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.3946 0 Td
(19)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(])Tj
2.9821 0 Td
(and)Tj
-35.206 -1.2982 Td
(further)Tj
3.0274 0 Td
(motivated)Tj
4.2519 0 Td
(us)Tj
1.1055 0 Td
(to)Tj
1.0262 0 Td
(perform)Tj
3.5206 0 Td
(a)Tj
0.6519 0 Td
(comprehensive)Tj
6.2872 0 Td
(analysis)Tj
3.3279 0 Td
(of)Tj
1.0148 0 Td
(PI3K-Akt)Tj
4.0988 0 Td
(signaling)Tj
3.821 0 Td
(in)Tj
1.0375 0 Td
(T-ALL.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 499.0677 cm
BT
/F14 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(A)Tj
0.9212 0 Td
(high)Tj
2.0929 0 Td
(throughput)Tj
5.0458 0 Td
(PI3K-Akt)Tj
4.2756 0 Td
(phospho-flow)Tj
5.9764 0 Td
(platform)Tj
3.9402 0 Td
(and)Tj
1.7906 0 Td
(PI3K)Tj
2.3811 0 Td
(isoforms)Tj
3.8788 0 Td
(in)Tj
-30.3026 -1.1669 Td
(T-ALL)Tj
3 0 Td
(patients)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 468.0566 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(To)Tj
1.3379 0 Td
(comprehensively)Tj
6.9902 0 Td
(examine)Tj
3.6 0 Td
(PI3K-Akt)Tj
4.0988 0 Td
(signaling)Tj
3.8211 0 Td
(in)Tj
1.0375 0 Td
(T-ALL,)Tj
3.1634 0 Td
(we)Tj
1.3323 0 Td
(developed)Tj
4.269 0 Td
(a)Tj
0.6519 0 Td
(high)Tj
2.0126 0 Td
(throughput)Tj
-32.3147 -1.3039 Td
(platform)Tj
3.702 0 Td
(with)Tj
1.9956 0 Td
(fluorescent)Tj
4.6374 0 Td
(cell)Tj
1.559 0 Td
(barcoding)Tj
4.2747 0 Td
(\(FCB\))Tj
2.6702 0 Td
(coupled)Tj
3.3902 0 Td
(to)Tj
1.0261 0 Td
(phospho-flow.)Tj
5.9868 0 Td
(FCB)Tj
1.9899 0 Td
(with)Tj
2.0012 0 Td
(different)Tj
-33.2331 -1.2982 Td
(concentrations)Tj
6.1794 0 Td
(of)Tj
1.0148 0 Td
(Pacific)Tj
2.88 0 Td
(Blue)Tj
2.0013 0 Td
(and)Tj
1.7291 0 Td
(Alexa)Tj
2.4718 0 Td
(Fluor)Tj
2.3981 0 Td
(488)Tj
1.6497 0 Td
(creates)Tj
2.9537 0 Td
(a)Tj
0.652 0 Td
(6x4)Tj
1.6384 0 Td
(matrix)Tj
2.8743 0 Td
(that)Tj
1.7802 0 Td
(allows)Tj
2.6985 0 Td
(us)Tj
1.1112 0 Td
(to)Tj
1.0205 0 Td
(stain,)Tj
-35.053 -1.2983 Td
(acquire,)Tj
3.3958 0 Td
(and)Tj
1.7348 0 Td
(analyze)Tj
3.1691 0 Td
(24)Tj
1.1736 0 Td
(samples)Tj
3.3845 0 Td
(in)Tj
1.0318 0 Td
(one)Tj
1.7008 0 Td
(tube)Tj
1.9786 0 Td
(followed)Tj
3.6453 0 Td
(by)Tj
1.1849 0 Td
(deconvolution)Tj
6.0037 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(Fig)Tj
1.8879 0 Td
(2A)Tj
0 g
/F8 1 Tf
(\).)Tj
1.9842 0 Td
(Intracellular)Tj
-32.275 -1.3039 Td
(staining)Tj
3.4072 0 Td
(of)Tj
1.0148 0 Td
(baseline)Tj
3.4299 0 Td
(pAkt)Tj
2.2166 0 Td
(\(S473\))Tj
2.8063 0 Td
(levels)Tj
2.3754 0 Td
(by)Tj
1.1793 0 Td
(phospho-flow)Tj
5.7599 0 Td
(in)Tj
1.0375 0 Td
(unstimulated)Tj
5.4992 0 Td
(T-ALL)Tj
2.9423 0 Td
(cells)Tj
1.9219 0 Td
(followed)Tj
-33.5903 -1.2983 Td
(by)Tj
1.1792 0 Td
(Cytobank)Tj
4.1328 0 Td
(software)Tj
3.583 0 Td
(analysis)Tj
3.3279 0 Td
(generated)Tj
4.1385 0 Td
(heat)Tj
1.8992 0 Td
(maps,)Tj
2.5795 0 Td
(which)Tj
2.6476 0 Td
(revealed)Tj
3.5263 0 Td
(the)Tj
1.4683 0 Td
(same)Tj
2.262 0 Td
(heterogeneity)Tj
5.6523 0 Td
(in)Tj
-36.3966 -1.2982 Td
(baseline)Tj
3.4298 0 Td
(pAkt)Tj
2.2167 0 Td
(levels)Tj
2.3754 0 Td
(as)Tj
1.0148 0 Td
(seen)Tj
1.9729 0 Td
(in)Tj
1.0375 0 Td
(Figs)Tj
0.83 0.64 0.02 0 k
1.8425 0 Td
(1)Tj
0 g
0.6973 0 Td
(and)Tj
1.7292 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(2A)Tj
0 g
/F8 1 Tf
(\).)Tj
2.3244 0 Td
(Using)Tj
2.6022 0 Td
(this)Tj
1.6724 0 Td
(platform,)Tj
3.9288 0 Td
(we)Tj
1.3266 0 Td
(also)Tj
1.7688 0 Td
(confirmed)Tj
4.3937 0 Td
(hetero-)Tj
-34.333 -1.2983 Td
(geneous)Tj
3.4752 0 Td
(changes)Tj
3.4016 0 Td
(in)Tj
1.0374 0 Td
(pAkt)Tj
2.2167 0 Td
(levels)Tj
2.3754 0 Td
(in)Tj
1.0375 0 Td
(T-ALL)Tj
2.9423 0 Td
(cell)Tj
1.5591 0 Td
(lines)Tj
2.0636 0 Td
(after)Tj
2.0353 0 Td
(cytokine)Tj
3.6396 0 Td
(stimulation)Tj
4.7962 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(Fig)Tj
1.8822 0 Td
(2B)Tj
0 g
/F8 1 Tf
(\).)Tj
-0.01 Tc
-31.2659 -1.3039 Td
(The)Tj
1.7688 0 Td
(four)Tj
1.8878 0 Td
(catalytic)Tj
3.4469 0 Td
(subunits)Tj
3.5717 0 Td
(of)Tj
1.0034 0 Td
(PI3K)Tj
2.2394 0 Td
(differ)Tj
2.3527 0 Td
(in)Tj
1.0205 0 Td
(their)Tj
2.0806 0 Td
(tissue)Tj
2.4208 0 Td
(distribution:)Tj
5.1193 0 Td
(PI3K)Tj
/F13 1 Tf
()Tj
/F8 1 Tf
2.8063 0 Td
(and)Tj
/F13 1 Tf
1.7121 0 Td
()Tj
/F8 1 Tf
0.703 0 Td
(are)Tj
-33.3295 -1.2983 Td
(expressed)Tj
4.0365 0 Td
(ubiquitously)Tj
5.1476 0 Td
(whereas)Tj
3.4073 0 Td
(expression)Tj
4.405 0 Td
(of)Tj
1.0034 0 Td
(the)Tj
/F13 1 Tf
1.4514 0 Td
()Tj
/F8 1 Tf
0.6746 0 Td
(and)Tj
/F13 1 Tf
1.7121 0 Td
(\r)Tj
/F8 1 Tf
0.669 0 Td
(isoforms)Tj
3.6567 0 Td
(is)Tj
0.8333 0 Td
(restricted)Tj
3.9288 0 Td
(to)Tj
1.0148 0 Td
(immune)Tj
3.5887 0 Td
(cells)Tj
-35.5292 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(27)Tj
0 g
(].)Tj
2.0466 0 Td
(According)Tj
4.3823 0 Td
(to)Tj
1.0148 0 Td
(the)Tj
1.4513 0 Td
(Immgen)Tj
3.6 0 Td
(database,)Tj
3.8097 0 Td
(T)Tj
0.8277 0 Td
(cells)Tj
1.8879 0 Td
(and)Tj
1.7121 0 Td
(their)Tj
2.0806 0 Td
(precursors)Tj
4.3937 0 Td
(express)Tj
3.1011 0 Td
(all)Tj
1.1282 0 Td
(four)Tj
1.8935 0 Td
(isoforms;)Tj
-33.3295 -1.3039 Td
(p110)Tj
/F13 1 Tf
()Tj
/F8 1 Tf
(,)Tj
/F13 1 Tf
2.9196 0 Td
()Tj
/F8 1 Tf
(,)Tj
/F13 1 Tf
0.9241 0 Td
()Tj
/F8 1 Tf
(,)Tj
0.8957 0 Td
(and)Tj
/F13 1 Tf
1.7122 0 Td
(\r)Tj
/F8 1 Tf
(.)Tj
0.89 0 Td
(Western)Tj
3.5717 0 Td
(blot)Tj
1.7518 0 Td
(analysis)Tj
3.2768 0 Td
(confirmed)Tj
4.3426 0 Td
(that)Tj
1.7575 0 Td
(all)Tj
1.1282 0 Td
(murine)Tj
3.1408 0 Td
(and)Tj
1.7121 0 Td
(human)Tj
3.05 0 Td
(T-ALL)Tj
2.9084 0 Td
(cell)Tj
1.5363 0 Td
(lines)Tj
-35.5178 -1.2982 Td
(tested)Tj
2.5171 0 Td
(expressed)Tj
4.0365 0 Td
(these)Tj
2.228 0 Td
(four)Tj
1.8879 0 Td
(isoforms)Tj
3.6567 0 Td
(at)Tj
0.9354 0 Td
(comparable)Tj
4.8472 0 Td
(levels.)Tj
2.5568 0 Td
(Levels)Tj
2.6306 0 Td
(were)Tj
2.0976 0 Td
(also)Tj
1.7461 0 Td
(roughly)Tj
3.2769 0 Td
(similar)Tj
2.948 0 Td
(to)Tj
-35.3648 -1.2983 Td
(those)Tj
2.3073 0 Td
(observed)Tj
3.7474 0 Td
(in)Tj
1.0205 0 Td
(normal)Tj
3.1124 0 Td
(murine)Tj
3.1408 0 Td
(thymocytes)Tj
4.7281 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(Fig)Tj
1.8595 0 Td
(2C)Tj
0 g
/F8 1 Tf
(\).)Tj
1.9333 0 Td
(An)Tj
1.44 0 Td
(analysis)Tj
3.2825 0 Td
(of)Tj
0.9977 0 Td
(113)Tj
1.6328 0 Td
(pediatric)Tj
3.6963 0 Td
(T-ALL)Tj
-32.8986 -1.3039 Td
(patient)Tj
2.965 0 Td
(samples)Tj
3.3392 0 Td
(confirmed)Tj
4.3426 0 Td
(similar)Tj
2.9424 0 Td
(expression)Tj
4.4106 0 Td
(levels)Tj
2.3358 0 Td
(of)Tj
1.0034 0 Td
(all)Tj
1.1282 0 Td
(four)Tj
1.8879 0 Td
(isoforms)Tj
3.6566 0 Td
(with)Tj
1.9729 0 Td
(little)Tj
1.9616 0 Td
(variation)Tj
-31.9462 -1.2983 Td
(between)Tj
3.4865 0 Td
(patients)Tj
3.3166 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(Fig)Tj
1.8595 0 Td
(2D)Tj
0 g
/F8 1 Tf
(\).)Tj
2.0182 0 Td
(Interestingly,)Tj
5.4085 0 Td
(we)Tj
1.3153 0 Td
(observed)Tj
3.7473 0 Td
(a)Tj
0.6463 0 Td
(modest)Tj
3.1238 0 Td
(inverse)Tj
3.0274 0 Td
(correlation)Tj
4.5524 0 Td
(between)Tj
-32.5018 -1.2982 Td
(RasGRP1)Tj
3.9628 0 Td
(expression)Tj
4.405 0 Td
(and)Tj
1.7178 0 Td
(the)Tj
1.4513 0 Td
(expression)Tj
4.405 0 Td
(of)Tj
1.0035 0 Td
(p110)Tj
/F13 1 Tf
()Tj
/F8 1 Tf
(,)Tj
/F13 1 Tf
2.9196 0 Td
()Tj
/F8 1 Tf
(,)Tj
0.9184 0 Td
(and)Tj
/F13 1 Tf
1.7122 0 Td
()Tj
/F8 1 Tf
(,)Tj
0.9014 0 Td
(but)Tj
1.5363 0 Td
(not)Tj
/F13 1 Tf
1.5534 0 Td
(\r)Tj
/F8 1 Tf
0.669 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(S1A)Tj
2.2337 0 Td
(Fig)Tj
0 g
/F8 1 Tf
(\).)Tj
2.0806 0 Td
(We)Tj
1.593 0 Td
(previously)Tj
-33.063 -1.2983 Td
(reported)Tj
3.6113 0 Td
(that)Tj
1.7518 0 Td
(T-ALL)Tj
2.914 0 Td
(patients)Tj
3.3221 0 Td
(with)Tj
1.9729 0 Td
(high)Tj
1.9843 0 Td
(RasGRP1)Tj
3.9628 0 Td
(expression)Tj
4.405 0 Td
(responded)Tj
4.3767 0 Td
(relatively)Tj
3.7814 0 Td
(well)Tj
1.7971 0 Td
(to)Tj
1.0091 0 Td
(treat-)Tj
-34.8885 -1.3039 Td
(ment)Tj
2.2847 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(S1B)Tj
2.1599 0 Td
(Fig)Tj
0 g
/F8 1 Tf
1.5251 0 Td
(and)Tj
1.7121 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(]\))Tj
1.6951 0 Td
(and)Tj
1.7121 0 Td
(also)Tj
1.7405 0 Td
(find)Tj
1.8311 0 Td
(that)Tj
1.7518 0 Td
(the)Tj
1.4514 0 Td
(lymphoblasts)Tj
5.4311 0 Td
(of)Tj
1.0035 0 Td
(patients)Tj
3.3165 0 Td
(in)Tj
1.0261 0 Td
(this)Tj
1.6498 0 Td
(dataset)Tj
2.9537 0 Td
(who)Tj
1.9218 0 Td
(failed)Tj
-35.1663 -1.2983 Td
(induction)Tj
4.0818 0 Td
(therapy)Tj
3.2031 0 Td
(express)Tj
3.1011 0 Td
(higher)Tj
2.7666 0 Td
(expression)Tj
4.405 0 Td
(of)Tj
1.0035 0 Td
(p110)Tj
/F13 1 Tf
2.143 0 Td
()Tj
/F8 1 Tf
0.6973 0 Td
(or)Tj
/F13 1 Tf
1.0885 0 Td
()Tj
/F8 1 Tf
0.6803 0 Td
(isoforms)Tj
3.651 0 Td
(\()Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
(S1C)Tj
2.2053 0 Td
(Fig)Tj
0 g
(\))Tj
/F8 1 Tf
(.)Tj
2.0863 0 Td
(The)Tj
1.7632 0 Td
(universal)Tj
-32.876 -1.2983 Td
(expression)Tj
4.405 0 Td
(of)Tj
1.0034 0 Td
(p110)Tj
/F13 1 Tf
()Tj
/F8 1 Tf
(,)Tj
/F13 1 Tf
2.9197 0 Td
()Tj
/F8 1 Tf
(,)Tj
/F13 1 Tf
0.9241 0 Td
()Tj
/F8 1 Tf
(,)Tj
0.8957 0 Td
(and)Tj
/F13 1 Tf
1.7121 0 Td
(\r)Tj
/F8 1 Tf
0.669 0 Td
(in)Tj
1.0261 0 Td
(T-ALL)Tj
2.9084 0 Td
(highlights)Tj
4.1158 0 Td
(the)Tj
1.4514 0 Td
(need)Tj
2.1203 0 Td
(to)Tj
1.0148 0 Td
(understand)Tj
4.7281 0 Td
(the)Tj
1.4514 0 Td
(role)Tj
1.7404 0 Td
(of)Tj
1.0035 0 Td
(all)Tj
1.1282 0 Td
(iso-)Tj
-35.2174 -1.3039 Td
(form-specific)Tj
5.4481 0 Td
(signaling)Tj
3.7701 0 Td
(events)Tj
2.6929 0 Td
(in)Tj
1.0261 0 Td
(order)Tj
2.3867 0 Td
(to)Tj
1.0148 0 Td
(design)Tj
2.778 0 Td
(effective)Tj
3.4582 0 Td
(therapeutic)Tj
4.6658 0 Td
(interventions.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 165.9968 cm
BT
/F14 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Pan-PI3K)Tj
4.3464 0 Td
(inhibitors)Tj
4.3607 0 Td
(but)Tj
1.6347 0 Td
(also)Tj
1.8614 0 Td
(PI3K)Tj
/F15 1 Tf
(\r)Tj
/F14 1 Tf
(-specific)Tj
6.3355 0 Td
(compounds)Tj
5.1024 0 Td
(extinguish)Tj
4.5685 0 Td
(all)Tj
1.2378 0 Td
(Akt)Tj
-29.4474 -1.1669 Td
(signals)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 134.9858 cm
BT
/F8 1 Tf
1 TL
-0.015 Tc
0 0 Td
(We)Tj
1.5873 0 Td
(next)Tj
1.9106 0 Td
(assessed)Tj
3.3845 0 Td
(the)Tj
1.4343 0 Td
(effects)Tj
2.6533 0 Td
(of)Tj
0.9921 0 Td
(using)Tj
2.33 0 Td
(available)Tj
3.5717 0 Td
(small)Tj
2.2677 0 Td
(molecule)Tj
3.753 0 Td
(compounds)Tj
4.8586 0 Td
(to)Tj
1.0034 0 Td
(inhibit)Tj
2.829 0 Td
(PI3K-Akt)Tj
-32.5755 -1.2982 Td
(signaling)Tj
3.7247 0 Td
(in)Tj
1.0091 0 Td
(T-ALL)Tj
2.8913 0 Td
(cell)Tj
1.5137 0 Td
(lines.)Tj
2.228 0 Td
(The)Tj
1.7461 0 Td
(IC50)Tj
2.1317 0 Td
(values)Tj
2.6022 0 Td
(of)Tj
0.9921 0 Td
(each)Tj
1.9842 0 Td
(PI3K)Tj
2.2224 0 Td
(and)Tj
1.7008 0 Td
(mTOR)Tj
2.9763 0 Td
(inhibitor)Tj
3.6794 0 Td
(used)Tj
2.0182 0 Td
(in)Tj
1.0091 0 Td
(this)Tj
-34.4293 -1.2983 Td
(study)Tj
2.3357 0 Td
(are)Tj
1.4116 0 Td
(shown)Tj
2.795 0 Td
(in)Tj
0.83 0.64 0.02 0 k
/F14 1 Tf
1.0148 0 Td
(Fig)Tj
1.508 0 Td
(3A)Tj
0 g
/F8 1 Tf
(.)Tj
1.6157 0 Td
(The)Tj
1.7462 0 Td
(mTOR)Tj
2.9763 0 Td
(inhibitor)Tj
3.685 0 Td
(serves)Tj
2.5455 0 Td
(as)Tj
0.9921 0 Td
(a)Tj
0.6463 0 Td
(positive)Tj
3.2259 0 Td
(control)Tj
3.0443 0 Td
(here)Tj
1.9219 0 Td
(since)Tj
2.1884 0 Td
(mTORC2)Tj
-33.6527 -1.3039 Td
(feeds)Tj
2.1883 0 Td
(directly)Tj
3.1408 0 Td
(into)Tj
1.7971 0 Td
(phosphorylation)Tj
6.65 0 Td
(of)Tj
0.9922 0 Td
(Akt)Tj
1.6667 0 Td
(at)Tj
0.9298 0 Td
(S473)Tj
2.0806 0 Td
([)Tj
0.83 0.64 0.02 0 k
(28)Tj
0 g
(].)Tj
2.0183 0 Td
(We)Tj
1.5873 0 Td
(observed)Tj
3.7077 0 Td
(uniform)Tj
3.4753 0 Td
(inhibition)Tj
4.1159 0 Td
(of)Tj
0.9921 0 Td
(pAkt)Tj
-35.3421 -1.2983 Td
(across)Tj
2.6078 0 Td
(all)Tj
1.1169 0 Td
(T-ALL)Tj
2.8856 0 Td
(cell)Tj
1.5137 0 Td
(lines)Tj
2.0126 0 Td
(using)Tj
2.3357 0 Td
(the)Tj
1.4343 0 Td
(pan-PI3K)Tj
4.0309 0 Td
(inhibitor)Tj
3.685 0 Td
(PIK-90,)Tj
3.2428 0 Td
(the)Tj
1.4343 0 Td
(dual)Tj
1.9106 0 Td
(PI3K/mTOR)Tj
5.3007 0 Td
(inhibitor)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 415.8425 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PI3)Tj
1.7008 0 Td
(kinase)Tj
3.0543 0 Td
(signaling)Tj
4.0819 0 Td
(analysis)Tj
3.763 0 Td
(in)Tj
0.978 0 Td
(T)Tj
0.8221 0 Td
(cell)Tj
1.6866 0 Td
(leukemia)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01938)Tj
4.089 0 Td
(49)Tj
0 g
2.0906 0 Td
(May)Tj
2.0906 0 Td
(25,)Tj
1.5803 0 Td
(2018)Tj
35.2349 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
89 0 obj
<>stream
endstream
endobj
90 0 obj
<>stream
endstream
endobj
91 0 obj
<>stream
endstream
endobj
92 0 obj
<>stream
endstream
endobj
93 0 obj
<>stream
endstream
endobj
94 0 obj
<>stream
endstream
endobj
95 0 obj
<>stream
endstream
endobj
96 0 obj
<>stream
endstream
endobj
97 0 obj
<>stream
endstream
endobj
98 0 obj
<>stream
endstream
endobj
99 0 obj
<>stream
endstream
endobj
100 0 obj
<>stream
endstream
endobj
101 0 obj
<>stream
endstream
endobj
102 0 obj
<>stream
BT
66.402 0 Td
(18)Tj
ET
Q
endstream
endobj
103 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 105 0 R/Contents 106 0 R/TrimBox[0 0 612 792]>>
endobj
104 0 obj
<>stream
xҭO))@LL C ]u[eYݽwY.J>,@ o7*b @ @ ^?~cw0~iD]sx]
ZիW^t\y#_Hl_~Q,|t߃|e)|o߾Uq"F*Ç
TgDG==SWd5iʲWƋ"#j5_+Lc?a, @ D@y8J܈BM#2jMRhB/W_)6IPTPq2RZ俳5jU9